Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-02-28 @ 11:42 PM
Study NCT ID:
NCT01918267
Status:
COMPLETED
Last Update Posted:
2018-05-11
First Post:
2013-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04-10
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-10
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-06
First Submit QC Date:
None
Study First Post Date:
2013-08-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-10
Last Update Post Date:
2018-05-11
Last Update Post Date Type:
ACTUAL